title: The impact of a citywide audit with educational intervention on the care of patients with epilepsy.
abstract: The care of patients with epilepsy historically has been well documented to be poor. Previous attempts to improve care through education have been unsuccessful. The New GP Contract in the UK introduced epilepsy as a core quality indicator from April 2004. This prospective audit assesses the impact of an audit with educational intervention on the process of care of patients with epilepsy. The case notes of 610 patients, of all ages, with epilepsy on treatment, in 13 general practices serving Chester and surrounding area were reviewed before and 2 years after an intervention, comprising (a) the provision of a comprehensive template, (b) individualised categorisation for each patient and (c) an educational session led by a Neurologist. The overall review rate increased in the first year from 41 to 49% (p<0.0001) and by 2 years to 63% (p<0.0001). Documented remission rate increased from 29 to 43% (p<0.0001). Admissions to accident and emergency fell significantly (p=0.0026). There was no fall in the non-compliance rate. Forty five percent of patients with documented poor control were not under shared care. Issues highlighted in the audit generated 77 referrals. There were clear health gains in 62 (13%) individuals from referrals and practice interventions related to the audit. This original audit identified significant improvements in review rate, documented remission rate and beneficial outcomes in individual patients. The changes were attributable to both the educational intervention and the coincidental acceptance of the New GP Contract. Remaining problems include lack of shared care for patients with active epilepsy.
authors.affiliation: Northgate Village Surgery, Northgate Avenue, Chester CH2 2DX, United Kingdom. ian.minshall@gp-n81121.nhs.uk
authors.forename: I
authors.initials: I
authors.lastname: Minshall
authors.forename: D
authors.initials: D
authors.lastname: Smith
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use*; D003133:Commission on Professional and Hospital Activities; D004827:Epilepsy / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D005791:Patient Care / Q000592:standards*; D010349:Patient Compliance / Q000706:statistics & numerical data; D010353:Patient Education as Topic / Q000592:standards*; D011320:Primary Health Care / Q000706:statistics & numerical data*; D012307:Risk Factors
chemical_list: D000927:Anticonvulsants